MacroGenics' recent royalty deal extends cash runway, but liquidity concerns remain, and further asset sales or dilution may ...

Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated ...

Corvus' soquelitinib shows promise in oncology & autoimmune fields, with Phase 3 PTCL data as a key catalyst. Click here to ...

The FDA is expected to decide on treatments for multiple myeloma, NSCLC, melanoma, phenylketonuria, and 2 rare kidney diseases.

A real-world analysis presented at ASCO Annual Meeting provided new insights into the effect BMI may have on how people with ...

Urological cancers are malignancies that affect the organs of the urinary system and male reproductive system. Of these, bladder ...

AstraZeneca's lengthy and turbulent development of CTLA4 inhibitor tremelimumab has at least led to a regulatory approval as part of a combination therapy for advanced liver cancer. Tremelimumab ...

When is The Witcher 4 release date? CD Projekt Red initially confirmed the existence of a new game in The Witcher series via a press release in March 2022 and a title update in October 2022.

Renal failure in multiple myeloma typically occurs when the kidneys fail to filter waste products from the blood, leading to ...

While we didn't see any new Fable 4 footage during the recent Summer Game Fest 2025 schedule, worry not, adventurers, because the game is still very much on the way...well, at least for now.

The M14TIL trial involved 168 patients with stage 3c to 4 melanoma that was too advanced to be treatable with surgery, most of whom (89%) had failed earlier treatment with PD-1 inhibitors like BMS ...